Condition: Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection · Hemolytic-Uremic Syndrome · Sponsor: University of Calgary
The objective of this study is to determine if early high volume intravenous fluid administration (hyperhydration) may be effective in mitigating or preventing complications of shiga toxin-producing E. coli (STEC) infection in children and adolescents when compared with traditional approaches (conservative fluid management).
This description comes directly from the study's public registry record.
Study Manager · (801) 581-6410 · hikostec@hsc.utah.edu
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Arkansas Children's Hospital | Little Rock, Arkansas, United States | Recruiting |
| University of California, San Diego | La Jolla, California, United States | Recruiting |
| University of California, Davis | Sacramento, California, United States | Recruiting |
| University of Colorado Denver | Denver, Colorado, United States | Recruiting |
| Children's Research Institute | Washington D.C., District of Columbia, United States | Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| Indiana University Children's Hospital | Indianapolis, Indiana, United States | Recruiting |
| University of Kentucky | Lexington, Kentucky, United States | Recruiting |
| Norton Children's Hospital | Louisville, Kentucky, United States | Recruiting |
| Children's Minnesota Hospital | Minneapolis, Minnesota, United States | Recruiting |
| Washington University | St Louis, Missouri, United States | Recruiting |
+ 14 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05219110